Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension

Primary aldosteronism (PA) is present in up to 20% of patients with treatment‐resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Hypertens (Greenwich)
Autori principali: Velasco, Alejandro, Chung, Oliver, Raza, Fayez, Pandey, Ambarish, Brinker, Stephanie, Arbique, Debbie, Price, Angela, Lotan, Yair, Das, Sandeep R., Vongpatanasin, Wanpen
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2015
Soggetti:
Original Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562815/
https://ncbi.nlm.nih.gov/pubmed/25917401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12570
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi